Zimmer Biomet logo

    Company profile

    Zimmer Biomet

    Profiled by the AIDE Institute

    Zimmer Biomet (ZBH) has an AIDE Index 2.0 (Sector) score of 55.47 out of 100, placing it #32 of 59 companies in the Health Care sector. Its Matrix Quadrant (Sector) is Health Care Emerging Adopters. The AIDE Index measures observable AI adoption through public evidence, scored against sector peers.

    Edition
    AIDE Index 2.0 · S&P 500 Round 2, 2026-Q3 · Current edition
    Matrix Quadrant (Sector)
    Emerging Adopter
    Health Care sector position
    #32
    of 59 Health Care peers
    AIDE Index 2.0 (Sector)
    AIDE Index 2.0 (Sector): 55.47 / 100

    Where does Zimmer Biomet sit among Health Care peers?

    Matrix Quadrant (Sector), AIDE Index 2.0: Health Care Emerging Adopters

    Horizontal axis: Strategic Intent. Vertical axis: Operational Integration. Each divider is the median of the same GICS sector in the same edition.

    • Stealth Adopters

      Lower Strategic Intent, higher Operational Integration

      • Abbott Laboratories logo
      • AbbVie logo
      • Becton Dickinson logo
      • Boston Scientific logo
      • Cardinal Health logo
      • Elevance Health logo
      • HCA Healthcare logo
      • Solventum logo
      • Stryker Corporation logo
    • AI Trailblazers

      Higher Strategic Intent, higher Operational Integration

    • Emerging Adopters

      Lower Strategic Intent, lower Operational Integration

      This company’s category

      • Zimmer Biomet logo
      • Baxter International logo
      • Bio-Techne logo
      • Cencora logo
      • Centene Corporation logo
      • Charles River Laboratories logo
      • Cooper Companies (The) logo
      • Edwards Lifesciences logo
      • Gilead Sciences logo
      • Henry Schein logo
      • Incyte logo
      • Insulet Corporation logo
      • Mettler Toledo logo
      • Quest Diagnostics logo
      • Regeneron Pharmaceuticals logo
      • Steris logo
      • Universal Health Services logo
      • Viatris logo
      • Waters Corporation logo
      • West Pharmaceutical Services logo
    • AI Visionaries

      Higher Strategic Intent, lower Operational Integration

      • Align Technology logo
      • Biogen logo
      • Danaher Corporation logo
      • DaVita logo
      • Humana logo
      • Vertex Pharmaceuticals logo
      • Zoetis logo

    Quadrants are assigned against the median of the same GICS sector in the same edition. Exact axis values and positions within a quadrant are not public.

    How the AIDE Matrix works

    Ticker
    ZBH
    GICS sector
    Health Care
    Industry
    Health Care Equipment
    1. Step 1

      Compare with a competitor

    2. Step 2

      Share your score

      Share this profile

      Post on LinkedIn (opens in a new tab)Email

    3. Step 3

      Want more?

      License AIDE data for the full peer set, pillar evidence and documented use cases.

      Request the full analysis

    Official company websitezimmerbiomet.com

    Side by side · Health Care · AIDE Index 2.0, current edition

    Compare companies

    Share on LinkedIn
    AIDE Index 2.0 (S&P 500 Round 2, 2026-Q3) same-sector company comparison
    Public evidence snapshot
    Zimmer Biomet logo
    Zimmer BiometZBH
    ResMed logo
    ResMedRMD
    Becton Dickinson logo
    Becton DickinsonBDX
    Stryker Corporation logo
    Stryker CorporationSYK
    AIDE Index 2.0 (Sector)55.47 / 100Up from previous edition+4.3%Competitor information lockedCompetitor information lockedCompetitor information locked
    Sector rank#32 of 59Down from previous edition7 positionsCompetitor information lockedCompetitor information lockedCompetitor information locked
    Matrix Quadrant (Sector)Health Care Emerging AdoptersCompetitor information lockedCompetitor information lockedCompetitor information locked
    Literacy (Sector)49.53Up from previous edition+36.4%Competitor information lockedCompetitor information lockedCompetitor information locked
    Advocacy (Sector)71.09Up from previous edition+9.5%Competitor information lockedCompetitor information lockedCompetitor information locked
    Orientation (Sector)47.92Down from previous edition-22.1%Competitor information lockedCompetitor information lockedCompetitor information locked
    Implementation (Sector)53.33Up from previous edition+6.7%Competitor information lockedCompetitor information lockedCompetitor information locked
    IndustryHealth Care EquipmentCompetitor information lockedCompetitor information lockedCompetitor information locked
    EditionAIDE Index 2.0 · S&P 500 Round 2, 2026-Q3Competitor information lockedCompetitor information lockedCompetitor information locked
    Next stepRequest the full analysisRequest the full analysisRequest the full analysisRequest the full analysis

    Enter your email to access competitor information

    Competitor values stay hidden until you submit the Health Care sector form. Zimmer Biomet stays visible.

    AIDE Index (Sector) is relative to companies in the same GICS sector and the same edition. It is not a cross-sector ranking. All values are from AIDE Index 2.0 (S&P 500 Round 2, 2026-Q3). This is a sector-relative signal, not a full organizational benchmark.

    Arrows compare the two published editions for each company. They show how published scores and ranks changed; they do not establish what caused the changes.

    Documented from public evidence

    How is Zimmer Biomet using AI?

    A small, selected preview of AI use by Zimmer Biomet that the AIDE Institute has documented from public sources such as filings, earnings calls and company announcements. It is not the complete set.

    Enter your email to access more information

    AIDE Index 2.0 · S&P 500 Round 2, 2026-Q3 · Current edition

    What does the AIDE Index show for Zimmer Biomet?

    This is a sector-relative signal for AIDE Index 2.0, not a full organizational benchmark.

    Enter your email to access more information

    Editions

    How do the published editions compare for Zimmer Biomet?

    Enter your email to access more information

    Quick answers about Zimmer Biomet

    What is Zimmer Biomet’s AIDE Index 2.0 (Sector) score?

    Zimmer Biomet has an AIDE Index 2.0 (Sector) score of 55.47 out of 100. The score is sector-relative: it compares Zimmer Biomet only with other Health Care companies.

    Where does Zimmer Biomet place in Health Care?

    Zimmer Biomet places #32 of 59 Health Care companies on AIDE Index 2.0 (Sector). #1 is the highest score in the sector.

    What is Zimmer Biomet’s Matrix Quadrant (Sector)?

    Zimmer Biomet’s Matrix Quadrant (Sector) is Health Care Emerging Adopters. The quadrant is assigned within the Health Care sector, not across all sectors.

    What do the four pillars show?

    Literacy reflects what leaders know, Advocacy what leaders say, Orientation what the organization prioritizes and Implementation what the organization builds. Each pillar (Sector) is scored from 0 to 100 against the same sector peer group. See the AIDE Index methodology.

    About this profile

    This public profile is a snapshot of the AIDE Index 2.0 (Sector) result for Zimmer Biomet: its score and position among Health Care companies, its four pillars and its Matrix Quadrant (Sector), measured from public evidence rather than surveys. The use-case summaries are a small, selected preview of documented AI use.

    It shows where Zimmer Biomet stands within its sector on the public record. Deeper interpretation, sector context and the source-linked evidence behind each result are part of AIDE’s full analysis, available by request.

    Definitions

    AIDE Index 2.0 (Sector)
    A 0 to 100 measure of observable AI adoption built from public evidence and scored against companies in the same GICS sector and edition. It does not establish financial returns or capture every internal AI initiative. See the AIDE Index methodology.
    Sector position
    Where the company places among Health Care companies on AIDE Index (Sector). #1 is the highest score in the sector.
    Matrix Quadrant (Sector)
    One of the four AI-Driven Enterprise Matrix quadrants, assigned within the sector. See how the AIDE Matrix works.
    Pillars (Sector)
    Literacy, Advocacy, Orientation and Implementation, each scored from 0 to 100 against the same sector peer group.

    Full company analysis

    What does the public evidence mean for Zimmer Biomet?

    Get the complete detected use-case portfolio, source-linked evidence, deployment context, competitor patterns and expert interpretation from AIDE’s enterprise AI research team.

    AIDE’s research leadership includes Paul Cheek, CEO and Co-Founder of AIDE and Senior Lecturer at MIT Sloan, alongside researchers and practitioners with experience in AI, strategy and enterprise transformation.

    More Health Care company profiles

    Companies placed near Zimmer Biomet on AIDE Index 2.0 (Sector).

    Beyond the public profile

    What does the public evidence mean for Zimmer Biomet?

    The public profile shows the approved signals. A full AIDE analysis examines the source record behind them and explains what the pattern means for Zimmer Biomet in its Health Care context. The work is built from public, verifiable evidence by a specialist research team focused on enterprise AI adoption.

    The analysis connects leadership, strategy, talent and deployed AI to the complete set of detected use cases, cited sources, deployment stages and reported outcomes. Company-reported claims remain clearly identified as claims.

    The full analysis is designed to:

    1. Distinguish stated AI ambition from observable execution.
    2. Explain how the four AIDE pillars combine within the correct sector context.
    3. Review the complete set of detected use cases and the evidence attached to each one.
    4. Surface evidence gaps, contradictions and unanswered questions that deserve follow-up.
    5. Produce a cited briefing for strategy, diligence and board-level discussion.

    AIDE’s research leadership includes Paul Cheek, CEO and Co-Founder of AIDE and Senior Lecturer at MIT Sloan, alongside researchers and practitioners with experience in AI, strategy and enterprise transformation.

    Request full analysis accessRequest another company